Dintsios, C. M., & Beinhauer, I. (2020). The impact of additive or substitutive clinical study design on the negotiated reimbursement for oncology pharmaceuticals after early benefit assessment in Germany. BMC.
Čikaški stil citiranjaDintsios, C. M., i I. Beinhauer. The Impact of Additive or Substitutive Clinical Study Design On the Negotiated Reimbursement for Oncology Pharmaceuticals After Early Benefit Assessment in Germany. BMC, 2020.
MLA način citiranjaDintsios, C. M., i I. Beinhauer. The Impact of Additive or Substitutive Clinical Study Design On the Negotiated Reimbursement for Oncology Pharmaceuticals After Early Benefit Assessment in Germany. BMC, 2020.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.